SCHEMBL5273221

SCHEMBL5273221

CC(C)NC(=O)c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)O)ccc32)c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.44
CASP3 P42574 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
ACE2 Q9BYF1 1/20 0.39
IP6K1 Q92551 1/20 0.39
IP6K3 Q96PC2 1/20 0.39
IP6K2 Q9UHH9 1/20 0.39
FFAR1 O14842 1/20 0.39
MAPT P10636 3/20 0.39
TP53 P04637 2/20 0.39
HPSE Q9Y251 1/20 0.39
KDM4E B2RXH2 1/20 0.38
NAMPT P43490 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845554 0.92 KMT2A (0.46) BACE1CASP3SMN1; SMN2ALDH1A1NPC1
SCHEMBL20710161 0.88 BACE1 (0.46) BACE1CASP3ALDH1A1KMT2AMEN1
SCHEMBL6655582 0.87 KMT2A (0.41) BACE1CASP3SMN1; SMN2ALDH1A1NPC1
SCHEMBL3143475 0.86 BACE1 (0.46) BACE1CASP3SMN1; SMN2RAB9AKMT2A
SCHEMBL6770244 0.86 BACE1 (0.46) BACE1CASP3SMN1; SMN2RAB9AKMT2A
SCHEMBL5270139 0.86 BACE1 (0.46) BACE1CASP3SMN1; SMN2KMT2AMEN1
SCHEMBL14477231 0.86 ROCK2 (0.44) BACE1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL3157920 0.85 BACE1 (0.42) BACE1CASP3SMN1; SMN2NPC1LMNA
SCHEMBL480667 0.85 KMT2A (0.44) BACE1SMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL480665 0.85 KMT2A (0.44) BACE1SMN1; SMN2ALDH1A1NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1830842-A1 MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES Boehringer Ingelheim International GmbH (DE) 2007-09-12 EP disclosed
WO-2006067168-A1 MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-06-29 WO disclosed